Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Oncology
Sort By
Newest First
1 / 21
1 / 21
Protein Degradation
PROTACS: Upgrading Small Molecule Inhibitors
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-24-NI-02
June 11, 2024
Clinical Trials
Optimizing Oncology and Rare Disease Clinical Trials by Focusing on Science and Aligning with both Patients and Investigators
Dave Selkirk
Ergomed
PAO-06-24-CL-09
May 30, 2024
FDA Approval
Possible New Hope for Metastatic Cancer Patients: Food and Drug Administration Grants Approval for Clinical Trials For Lamassu's Groundbreaking Cancer Treatment Protocol
Lamassu Biotech
PR-M04-24-01
April 19, 2024
Clinical Trial Enrollment
NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial
NMDP
PR-M03-24-01
March 05, 2024
Vaccines
Delivering a Next-Generation COVID-19 Vaccine for Immunocompromised Patients and Novel Cancer Vaccines
David Dodd; Mark Newman, Ph.D.
GeoVax Inc.
PAO-10-23-CL-07
November 09, 2023
Microbiome
Modifying the Gut Microbiome to Improve CAR-T, HSCT, and Other Therapeutic Responses
Stacy Burns-Guydish, Ph.D.
List Labs
PAO-10-23-CL-07-33
November 01, 2023
Cell Therapy
Creating Efficiencies in Engineered Cell Therapy Development with Comprehensive Electroporation Support
Sarah Meeks, Ph.D.
MaxCyte
PAO-09-23-CL-09
September 28, 2023
Oncology
Addressing Cancer Therapy Resistance by Targeting Translational Regulation
Steve Worland, Ph.D.
eFFECTOR
PAO-06-23-CL-02
June 01, 2023
Tumor Microenvironment
Harnessing the Power of the Tumor Microenvironment with First-in-Class Therapies
Gil Efron
Purple Biotech
PAO-03-23-CL-01
March 21, 2023
Bone Regeneration
A Novel Technology Platform for Bone Regeneration and Cancer Treatment
Denis Dufrane, M.D., Ph.D.
PAO-03-23-CL-06
March 20, 2023
Collaboration
AbbVie and Anima Biotech Announce Collaboration for the Discovery and Development of mRNA Biology Modulators against Oncology and Immunology Targets
Anima Biotech
PR-M01-23-01-166
January 10, 2023
Immuno-Oncology
Targeted Immune System Activation: A Paradigm Shift in Immuno-oncology
Dan Passeri, M.Sc., J.D.
Cue Biopharma
PAO-12-022-CL-01
January 04, 2023
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06
October 11, 2022
Theranostics
Theranostic Manufacturing Solutions
Muctarr Sesay, Ph.D.
GBI
PAO-08-022-CL-07
August 29, 2022
Immuno-Oncology
Building Multiple Platforms to Address Difficult-to-Treat Cancers
Derek Hennecke
Inceptor Bio
PAO-05-22-R250-09
May 24, 2022
Oncology
Fighting Cancer and Supporting Patients
Gibson Oncology
PAO-04-22-R250-13
April 12, 2022
Oncology Collaboration
Tegmine Therapeutics Announces Collaboration with Alloy Therapeutics to Advance Solid Tumor Treatment
Tegmine Therapeutics
PR-M04-22-03
April 06, 2022
Cancer Genetics
Developing RNA Screening for Cancer Diagnosis
Calviri
PAO-04-22-R250-08
April 05, 2022
Phase I Trial
Anixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase I Trial at Moffitt Cancer Center
Anixa Biosciences
PR-M03-22-17
March 30, 2022
Oncology
Changing the Paradigm of Cancer Drug Discovery and Development with Plants
Martin Brenner, DVM, Ph.D.; Randy Maddux; Steven King
iBio, Inc.
PAO-02-022-CL-02
March 12, 2022